Trial Profile
Effect of Testosterone Replacement on Insulin Resistance in Hypogonadal, Non-Obese Men With Metabolic Syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacodynamics
- 03 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2010 Planned end date changed from 1 Dec 2008 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 30 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.